Detalhe da pesquisa
1.
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
J Infect
; 85(3): 306-317, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35718205